Vascugen

📍 Madison, United States🗓 Founded 2017👥 10 employees💰 Last funded May 2020
Biotechnology🌐 vascugen.com
Website LinkedIn
Vascugen is dedicated to revolutionizing the standard of care for millions of patients suffering from severe conditions caused by restricted blood flow, particularly for those patients at high risk for amputation and death for whom few to no treatment options remain. The company’s lead product is an allogeneic vasculogenic cell – a cell with the potential to forge new blood vessels in oxygen-starved tissues. The vasculogenic cell product is manufactured from induced pluripotent stem cells (iPSCs), which provide a limitless source from which to produce off-the-shelf, cryopreserved doses at scale.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Vascugen?
Vascugen has 1 investors on record on gritt.io, 1 mid-stage.
When did Vascugen last raise funding?
The most recent investment in Vascugen recorded on gritt.io was in May 2020.
When was Vascugen founded?
Vascugen was founded in 2017.
What industry is Vascugen in?
Vascugen operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Vascugen based?
Vascugen is headquartered in Madison, United States.